1998 - Fellow of the Royal Society of Canada Academy of Science
Robert G. Korneluk focuses on Inhibitor of apoptosis, Cell biology, XIAP, Cancer research and Apoptosis. Robert G. Korneluk is involved in the study of Inhibitor of apoptosis that focuses on Baculoviral IAP repeat-containing protein 3 in particular. His Baculoviral IAP repeat-containing protein 3 study combines topics in areas such as Apoptosis Inhibitor, NAIP and Inhibitor of apoptosis domain.
The Kinase research Robert G. Korneluk does as part of his general Cell biology study is frequently linked to other disciplines of science, such as Vascular endothelial growth factor C, therefore creating a link between diverse domains of science. The XIAP study combines topics in areas such as Cancer cell, Molecular biology and Hippocampus, Morris water navigation task. The concepts of his Cancer research study are interwoven with issues in Signal transduction, Signal transducing adaptor protein, Carcinogenesis, Transcription factor and Immunology.
His main research concerns Inhibitor of apoptosis, Genetics, XIAP, Apoptosis and Cancer research. The various areas that Robert G. Korneluk examines in his Inhibitor of apoptosis study include Tumor necrosis factor alpha, Immunology, Signal transduction, Cell biology and Innate immune system. His Genetics study typically links adjacent topics like Molecular biology.
His XIAP research incorporates elements of Retinal degeneration, Baculoviral IAP repeat-containing protein 3, Endocrinology, Internal medicine and Inhibitor of apoptosis domain. His research in Apoptosis intersects with topics in Downregulation and upregulation, Transfection and Oncolytic virus. Robert G. Korneluk has researched Cancer research in several fields, including Cancer cell, Cancer, Survivin, Carcinogenesis and Cytokine.
Robert G. Korneluk mainly focuses on Inhibitor of apoptosis, Cancer research, Apoptosis, Tumor necrosis factor alpha and Cancer cell. Robert G. Korneluk has included themes like XIAP, Innate immune system, Immune system and Signal transduction, Cell biology in his Inhibitor of apoptosis study. His XIAP study is related to the wider topic of Genetics.
His study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Smac mimetics and Immune checkpoint inhibitors. His work on Programmed cell death as part of general Apoptosis research is frequently linked to Rhabdomyosarcoma, bridging the gap between disciplines. His Tumor necrosis factor alpha study integrates concerns from other disciplines, such as Cytotoxic T cell, Caspase and Activator.
Robert G. Korneluk spends much of his time researching Inhibitor of apoptosis, Innate immune system, Cell biology, Apoptosis and XIAP. His studies deal with areas such as Internal medicine, Signal transduction, Immunology and Endocrinology as well as Inhibitor of apoptosis. His Immunology study frequently links to other fields, such as Cancer research.
His work focuses on many connections between Innate immune system and other disciplines, such as Tumor necrosis factor alpha, that overlap with his field of interest in Immunity, Pharmacology, Proinflammatory cytokine and Oncolytic virus. His studies in Cell biology integrate themes in fields like Pattern recognition receptor and NOD1. Robert G. Korneluk interconnects Cancer cell, Inflammation, Necrosis and Macrophage in the investigation of issues within Apoptosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
Cun Yu Wang;Marty W. Mayo;Robert G. Korneluk;David V. Goeddel.
Science (1998)
The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
Eric C LaCasse;Stephen Baird;Stephen Baird;Robert G Korneluk;Robert G Korneluk;Alex E MacKenzie;Alex E MacKenzie.
Oncogene (1998)
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
Liston P;Roy N;Tamai K;Lefebvre C;Lefebvre C.
Nature (1996)
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
Natalie Roy;Natalie Roy;Mani S. Mahadevan;Michael McLean;Michael McLean;Gary Shutter.
Cell (1995)
Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK
Brian J Zarnegar;Yaya Wang;Douglas J Mahoney;Paul W Dempsey.
Nature Immunology (2008)
The inhibitors of apoptosis (IAPs) as cancer targets.
Allison M. Hunter;Eric C. LaCasse;Robert G. Korneluk;Robert G. Korneluk.
Apoptosis (2007)
IAP-targeted therapies for cancer
E C LaCasse;E C LaCasse;D J Mahoney;D J Mahoney;H H Cheung;H H Cheung;S Plenchette;S Plenchette.
Oncogene (2008)
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia
D H MacLennan;C Duff;F Zorzato;J Fujii.
Nature (1990)
The inhibitors of apoptosis: there is more to life than Bcl2.
Peter Liston;Wai Gin Fong;Robert G Korneluk;Robert G Korneluk.
Oncogene (2003)
Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.
Peter Liston;Wai Gin Fong;N. Lynn Kelly;Shingo Toji.
Nature Cell Biology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Children's Hospital of Eastern Ontario
Carleton University
Ottawa Hospital Research Institute
University of Florida
University of Toronto
Montreal Neurological Institute and Hospital
University of Ottawa
The Ohio State University
University of Toronto
University of Hong Kong
University of Rome Tor Vergata
Australian National University
Nanyang Technological University
Rutherford Appleton Laboratory
University of Hyogo
Istituto Superiore per la Protezione e la Ricerca Ambientale
Artois University
Bose Institute
University of Eastern Piedmont Amadeo Avogadro
Osaka University
Hiroshima University
Institut Pasteur
University of Western Ontario
Wake Forest University
University of Alabama at Birmingham
La Jolla Institute For Allergy & Immunology